Leading players such as Novo Nordisk and Eli Lilly are expanding production capacity through acquisitions and outsourcing to meet rising GLP-1 demand
Current understanding is based on ongoing clinical trials and early stage research
They include illegal drugs, such as heroin, and strong prescription pain relievers, such as morphine (Kadian, MS Contin) and oxycodone (Oxycontin, Percocet)
Literature and video were very helpful
Because of this severe limitation, medical professionals historically had to rely on intravenous (IV) glutathione infusions to achieve meaningful therapeutic levels in patients with chronic illness
If pancreatitis is suspected during GLP-1 agonist treatment, the medication should be stopped immediately as directed in the SmPC